DENVER – Revelstoke Capital Partners, a growth-oriented health care-focused private equity firm, has completed a recapitalization of AOM Infusion, a specialty infusion provider focused on chronic therapy management.
AOM Infusion provides patients with intravenous immunoglobulin, biologics and other therapies, addressing more than 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The company also provides support services, including skilled infusion nursing administration, pharmacy services, referral management, insurance verification and patient education and training.
“AOM is committed to growth that enhances patient care,” said Keyur Mehta, CEO of AOM. “We are excited about the new partnership with Revelstoke, and we look forward to extending our reach by expanding our therapeutic focus areas, deepening our clinical expertise and ensuring that patients receive the highest quality infusion therapy in the most comfortable and cost-effective care settings.”
AOM is the ninth investment from Revelstoke Capital Partners Fund III.
Terms of the transaction were not disclosed.
About AOM: The company was founded in 1994 and holds pharmacy licenses in all 50 states.
About Revelstoke: The firm has about $4.8 billion of assets under management. Since its inception in 2013, it has completed 195 acquisitions, which include 30 platform companies and 165 add-on acquisitions.
The M&A market for healthcare companies continues to build on STRATEGIC opportunities and a fragmented market. Consolidations along with unprecedented demand are driving scale across the continuum of care. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
